Some NHS patients wrongly diagnosed with type 2 diabetes
‘Groundbreaking’ drug could slow down progression of type 1 diabetes
At least 55,000 NHS patients may require new blood tests for type 2 diabetes due to inaccurate results from faulty machines.
The errors were caused by machines manufactured by a US and Ireland-based company, Trinity Biotech, leading to some patients being wrongly diagnosed and prescribed unnecessary medication.
The issue affects 16 hospital trusts across the UK, with the problem first identified last year by Bedfordshire NHS Foundation Trust.
Concerns about the accuracy of these haemoglobin A1C tests were reported in April 2024, according to the medicines and healthcare regulator (MHRA).
NHS England confirmed that affected laboratories have either replaced the machines or addressed calibration issues, and patients needing re-tests will be contacted.